Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,270,064
+$2,840,764 QoQ
Shares Held
135,800
+687.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#770
of 2,821 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $11,151,833 across 4 Drug Manufacturers - General names. PFE ranks #2 (29.3% of the industry book) .
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,270,064 | 135,800 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $429,300 | 17,241 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $14,342,895 | 562,908 | Shares | Sole | 2025-11-13 | |
| 2024-03-31 | $582,750 | 21,000 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $4,097,095 | 100,419 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,303,955 | 64,480 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $1,926,959 | 36,753 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,561,020 | 30,153 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,264,437 | 21,413 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,212,322 | 28,187 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,830,377 | 46,741 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,328,465 | 64,269 | Shares | Sole | 2021-07-21 | |
| 2020-12-31 | $637,475 | 17,318 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,118,321 | 30,472 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $3,464,503 | 105,948 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||